Prof. Lydia Bourouiba is the faculty recipient of the 2023 Paul Gray Award for Public Service. Her expertise was essential in informing infectious disease policy during the COVID-19 Pandemic. Congrats!🎉
https://t.co/46N6rOC9vp
Emery Brown stepped down after 10 years as co-director @mit_hst to help create new joint center b/w @MIT and MGH on use of #anesthesia to reveal new insights into brain diseases+dev. of treatments. @MIT_IMES@techreview read here: https://t.co/cN4bzNmBVE
New data alert!! 🚨🚨🚨
PointCheck(TM), our device for at-home noninvasive white cell monitoring, demonstrates high usability in #cancer patients. #impact#innovation
Big kudos to our collaborators @The_BMC@SaludMadrid@MIT_IMES and @NCIsbir.
https://t.co/xSaoZ8ceXD
The first Fluids and Health conference was fantastic. This looks to be every bit as exciting. If you do work involving fluids and health (even if not related to disease transmission) you should attend! @FluidsAndHealth
Fantastic line up of speakers and rich panel of participants and discussion leaders. Learn more about the F&H 2022 in the form of the new Fluids in Disease Transmission and Contamination Gordon Research Conference: August 14-19 2022 https://t.co/tVz1SyeeAf. APPLY BY JULY 13TH!
We're excited about the future of @mit_hst, + the possibilities for the next gen. of clinician-scientist-engineers, as Prof. Collin M. Stultz steps into the role of co-director of HST/assoc. director of @MIT_IMES! @MITEECS@RLEatMIT@MIT_CSAIL https://t.co/6I8UGGyZsJ
We're so proud of Emery N. Brown, @MIT_IMES@mit_hst who wins a share of the 2022 Gruber Neuroscience Prize, along with 3 other scientists, recognized for advancing statistical, theoretical analyses of neuroscience data! @MIT_Picower@The_Gruber_Fdtn https://t.co/6vDk8Me5Bm
We're proud of @ellentroche (Grand Prize Winner of the MIT Future Founders Initiative Prize Competition) + @snbhatia , one of the initiative's founders! The goal is to encourage women to pursue entrepreneurship in #biotech@MIT_IMES@mit_hst https://t.co/KmcTp7T1k1
A gem for those who still debate academia “versus” industry. The present reality is that all in industry were once in academia, as trainees or scholars, and many in industry will return to teach, advise, investigate. The era of the One Way ticket is firmly over, buy the bus pass!